Navigation Links
Clinical Renal Trails Do Not Have Sufficient Women Participants

New findings that are being presented during the American Society of Nephrology’s 38th Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania, say that women are not being adequately represented during medical trials // more specifically renal trials. Through analyses of the recently conducted renal trials showed this shortcoming.

It is theorized that this may be the reason why the US Food and Drug Administration (FDA) decided to withdraw many of these drugs from the market. It was found that over the last ten years, 8 out of 10 drugs that were ordered to be withdrawn had serious side effects in women. Dr. Julia Lewis of Vanderbilt University’s Division of Nephrology says that even with the above evidence women were underrepresented at clinical renal trials that were conducted to test the efficacy of certain drugs. She will speak at the symposium and say that pathogenesis of progressive renal disease and hypertension is dependent to some extent on sex hormones and ignoring these potentially harmful effects could adversely impact the health of women. Dr. Lewis is scheduled to speak at length on a topic titled “Gender Issues in Large Clinical Renal Trials,” during a symposium entitled, The Pathophysiology of Progressive Renal Disease and Hypertension: Importance of Gender and Ethnicity.

The meeting is being held from November 8-13 at the Pennsylvania Convention Center in Philadelphia, PA and focuses on distributing the latest research and clinical findings on kidney diseases among 12,000 nephrologists who assemble at the gathering
'"/>




Page: 1

Related medicine news :

1. Clinical trials need to be more frank
2. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
3. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
4. Clinical Comparisons Between ADHD Drugs Are Less
5. A Novel System For Clinical Banking Of Umbilical Cord Blood
6. Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment
7. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
8. Green Tea Consumption Found To Improve Clinical Outcome In Cancer Patients
9. Cancer Clinical Research in India
10. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
11. Clinical Impact of Activity and Abdominal Pressure on Pelvic Floor Dysfunction Need to Be Further Analyzed
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/26/2017)... ... July 26, 2017 , ... A major challenge many labs face is ... samples and a lengthy freeze dry cycle are a few common challenges that can ... as well as new accessories and advancements in laboratory freeze dryers that will improve ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... host its 2017 Process Validation and Process Validation Statistics Conferences in Bethesda, ... process validation lifecycle challenges faced by process validation professionals and statisticians today. ...
(Date:7/26/2017)... ... 26, 2017 , ... Team Type 1 Foundation, a nonprofit organization pursuing a ... diabetes, is excited to announce the 106 college athletes with type 1 diabetes who ... 2005, the Team Type 1 Foundation has bestowed a total of 271 college scholarships ...
(Date:7/26/2017)... ... , ... IDC-Eating Disorder Care is excited to announce Dr. Tracey ... Oak, Michigan. IDC, formerly known as Inner Door Center, was acquired in ... in the field of eating disorder treatment in the state of Michigan. ...
(Date:7/26/2017)... ... ... Wendy M. Musielak, a partner at the Andrew Cores Family Law Group, ... Vice President earlier this year. She will serve the membership in this capacity for a ... accordance with the organization’s by-laws. , Musielak joined the Andrew Cores Family ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... , July 13, 2017  New York City-based market research ... markets should be aware of.  From new products to new ... detailed in a recently completed study, Potential Pipeline Disruptors ... 1.  Age-Driven Growth - True ... been aware of the impact the growing population and, to ...
(Date:7/11/2017)...  Bayer has awarded grants totaling more than $2 million ... prestigious Bayer Hemophilia Awards Program (BHAP). Four U.S. clinicians and ... and Uniformed Services University of the Health Sciences in ... recipients were announced last night during a reception at the ... Berlin, Germany . ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
Breaking Medicine Technology: